InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Jiangsu Hengrui Pharmaceuticals Co., Ltd.. Officer active across 2 companies, notably Kailera Therapeutics, Inc.. Cumulatively, 3 filings have been published. Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations